Gene · 6529
Papers1,693
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,693
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CatPred: a comprehensive framework for deep learning in vitro enzyme kinetic parameters. | Nat Commun | 2025 | 40021618 | PubTator, text mining | PubMed |
| GABA transporter 1 is a promising drug target for CUL4B mutation-associated epilepsy. | Acta Pharmacol Sin | 2025 | 39984621 | PubTator, text mining | PubMed |
| GABAergic modulation of beta power enhances motor adaptation in frontotemporal lobar degeneration. | Alzheimers Dement | 2025 | 39968697 | PubTator, text mining | PubMed |
| Evidence for low affinity of GABA at the vesicular monoamine transporter VMAT2 - Implications for transmitter co-release from dopamine neurons. | Neuropharmacology | 2025 | 39961377 | PubTator, text mining | PubMed |
| 4-Phenylbutyrate restored GABA uptake, mitigated seizures in SLC6A1 and SLC6A11 microdeletions/3p- syndrome: From cellular models to human patients. | Epilepsy Res | 2025 | 39923323 | PubTator, text mining | PubMed |
| Behavioral, neurodevelopmental profile, and epilepsy trajectory in two series of SLC6A1-NDD: A retrospective study with comprehensive assessment, and a participatory database study. | Eur J Paediatr Neurol | 2025 | 39889538 | PubTator, text mining | PubMed |
| Multifunctional, Fluorene-Based Modulator of Cholinergic and GABAergic Neurotransmission as a Novel Drug Candidate for Palliative Treatment of Alzheimer's Disease. | Angew Chem Int Ed Engl | 2025 | 39523866 | PubTator, text mining | PubMed |
| Causative Role of the SLC6A1 p.Asp451Gly Variant in a Patient with Combined Dystonia and Neurodevelopmental Disorder. | Mov Disord Clin Pract | 2025 | 39446029 | PubTator, text mining | PubMed |
| Clinical and genetic analysis of epilepsy with myoclonic-atonic seizures caused by SLC6A1 gene variant. | Front Pediatr | 2024 | 39906729 | PubTator, text mining | PubMed |
| Construction of a prognostic model based on disulfidptosis-related genes and identification of CCNA2 as a novel biomarker for hepatocellular carcinoma. | Biol Direct | 2024 | 39695705 | PubTator, text mining | PubMed |
| Association between microenvironment-related genes and prognosis of primary central nervous system lymphoma. | EJHaem | 2024 | 39691244 | PubTator, text mining | PubMed |
| Improvement of variant reclassification in genetic neurodevelopmental conditions. | Genet Med Open | 2024 | 39669614 | PubTator, text mining | PubMed |
| AAV9/SLC6A1 gene therapy rescues abnormal EEG patterns and cognitive behavioral deficiencies in Slc6a1-/- mice. | J Clin Invest | 2024 | 39589822 | PubTator, text mining | PubMed |
| Optogenetic stimulation of the "Zusanli" acupoint alleviates inflammatory pain through active Wnt/β-Catenin and MAPK signaling pathway in rats. | Heliyon | 2024 | 39553603 | PubTator, text mining | PubMed |
| Modulation of SNARE-dependent exocytosis in astrocytes improves neuropathology in Huntington's disease. | Dis Model Mech | 2024 | 39526491 | PubTator, text mining | PubMed |
| Rational Search for Betaine/GABA Transporter 1 Inhibitors─In Vitro Evaluation of Selected Hit Compound. | ACS Chem Neurosci | 2024 | 39425769 | PubTator, text mining | PubMed |
| Different gene expression patterns between mouse and human brain pericytes revealed by single-cell/nucleus RNA sequencing. | Vascul Pharmacol | 2024 | 39423955 | PubTator, text mining | PubMed |
| Disrupting stroke-induced GAT-1-syntaxin1A interaction promotes functional recovery after stroke. | Cell Rep Med | 2024 | 39423810 | PubTator, text mining | PubMed |
| GABAergic dysfunction in postmortem dorsolateral prefrontal cortex: implications for cognitive deficits in schizophrenia and affective disorders. | Front Cell Neurosci | 2024 | 39381500 | PubTator, text mining | PubMed |
| SLC6A1 patient & organization perspective: founding of SLC6A1 connect, research, and ongoing efforts. | Ther Adv Rare Dis | 2024 | 39380901 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6529/papers?page=5